The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Ellman, G. L. (1959) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(59)90090-6 · Cited by 26,311
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Mitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
Handbook of methods for oxygen radical research
Greenwald, R. A. (1987) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(87)80012-6 · Cited by 2,381
Molecular mechanisms of resistance and toxicity associated with platinating agents
Rabik, C. A., & Dolan, M. E. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.09.006 · Cited by 1,564
Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex
Zhang, D. D., Lo, S.-C., Cross, J. V., Templeton, D. J., & Hannink, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10941-10953.2004 · Cited by 1,254
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-074903-4.x5000-6 · Cited by 1,073
Arany, I., & Safirstein, R. L. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00089-5 · Cited by 906
Mechanisms of resistance to cisplatin
Kartalou, M., & Essigmann, J. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00141-5 · Cited by 869
Mitochondrial permeability transition: a common pathway to necrosis and apoptosis
Kim, J.-S., He, L., & Lemasters, J. J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00618-1 · Cited by 755
Cardiotoxicity of Chemotherapeutic Agents: Incidence, Treatment and Prevention
Pai, V. B., & Nahata, M. C. (2000) · Drug Safety · doi:10.2165/00002018-200022040-00002 · Cited by 729
Nuclear activators and coactivators in mammalian mitochondrial biogenesis
Scarpulla, R. C. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00343-3 · Cited by 631
Anticancer Drug???Induced Kidney Disorders: Incidence, Prevention and Management
Kintzel, P. E. (2001) · Drug Safety · doi:10.2165/00002018-200124010-00003 · Cited by 355
Ali, B. H., & Al Moundhri, M. S. (2006) · Food and Chemical Toxicology · doi:10.1016/j.fct.2006.01.013 · Cited by 328
Silybum marianum (Carduus marianus)
Morazzoni, P., & Bombardelli, E. (1995) · Fitoterapia · Cited by 299
Cisplatin Induces Apoptosis in LLC-PK1 Cells via Activation of Mitochondrial Pathways
Park, M. S., De Leon, M., & Devarajan, P. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134858 · Cited by 279
Nephrotoxicity and Hydration Management for Cisplatin, Carboplatin, and Ormaplatin
Cornelison, T. L., & Reed, E. (1993) · Gynecologic Oncology · doi:10.1006/gyno.1993.1184 · Cited by 270
Yang, Z., Schumaker, L. M., Egorin, M. J., Zuhowski, E. G., Guo, Z., & Cullen, K. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1037 · Cited by 267
Preuss, H. G., Jarrell, S. T., Scheckenbach, R., Lieberman, S., & Anderson, R. A. (1998) · Journal of the American College of Nutrition · doi:10.1080/07315724.1998.10718736 · Cited by 261
Yousef, M. I., Saad, A. A., & El-Shennawy, L. K. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.02.007 · Cited by 247
Naringenin attenuates cisplatin nephrotoxicity in rats
Badary, O. A., Abdel-Maksoud, S., Ahmed, W. A., & Owieda, G. H. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.11.005 · Cited by 230
Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review
Pinzani, V., Bressolle, F., Johanne Haug, I., Galtier, M., Blayac, J. P., & Balm�s, P. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686277 · Cited by 217
Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients
Weijl, N. I., Hopman, G. D., Wipkink-Bakker, A., Lentjes, E. G. W. M., Berger, H. M., Cleton, F. J., & Osanto, S. (1998) · Annals of Oncology · doi:10.1023/a:1008407014084 · Cited by 214
Uptake, recycling, and antioxidant actions of α-lipoic acid in endothelial cells
Jones, W., Li, X., Qu, Z.-C., Perriott, L., Whitesell, R. R., & May, J. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00862-6 · Cited by 208
Cisplatin-induced apoptosis in auditory cells: role of death receptor and mitochondrial pathways
Devarajan, P., Savoca, M., Castaneda, M. P., Park, M. S., Esteban-Cruciani, N., Kalinec, G., & Kalinec, F. (2002) · Hearing Research · doi:10.1016/s0378-5955(02)00634-2 · Cited by 204
L-Propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector
Vanella, A., Russo, A., Acquaviva, R., Campisi, A., Di Giacomo, C., Sorrenti, V., & Barcellona, M. L. (2000) · Cell Biology and Toxicology · doi:10.1023/a:1007638025856 · Cited by 196
Buhl, S. N., & Jackson, K. Y. (1978) · Clinical Chemistry · doi:10.1093/clinchem/24.5.828 · Cited by 191
Karthikeyan, K., Bai, B. R. S., & Devaraj, S. N. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.03.016 · Cited by 190
l-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine
Chang, B., Nishikawa, M., Sato, E., Utsumi, K., & Inoue, M. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00342-9 · Cited by 175
Petersen Shay, K., Moreau, R. F., Smith, E. J., & Hagen, T. M. (2008) · IUBMB Life · doi:10.1002/iub.40 · Cited by 170
Wiseman, H. (1996) · The Journal of Nutritional Biochemistry · doi:10.1016/0955-2863(95)00152-2 · Cited by 169
Satoh, M., Kashihara, N., Fujimoto, S., Horike, H., Tokura, T., Namikoshi, T., Sasaki, T., & Makino, H. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047522 · Cited by 168
Protective Effects of Capsaicin against Cisplatin-Induced Nephrotoxicity in Rats
Shimeda, Y., Hirotani, Y., Akimoto, Y., Shindou, K., Ijiri, Y., Nishihori, T., & Tanaka, K. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1635 · Cited by 156
Ajith, T. A., Usha, S. Z., & Nivitha, V. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.06.011 · Cited by 146
Mitochondrial density determines the cellular sensitivity to cisplatin-induced cell death
Qian, W., Nishikawa, M., Haque, A. M., Hirose, M., Mashimo, M., Sato, E. F., & Inoue, M. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00265.2005 · Cited by 133
Bestimmung der Aktivit�t von Creatinkinase MB im Serum unter Verwendung inhibierender Antik�rper
W�rzburg, U., Hennrich, N., Lang, H., Prellwitz, W., Neumeier, D., & Knedel, M. (1976) · Journal of Molecular Medicine · doi:10.1007/bf01469790 · Cited by 125
Caffeic acid phenethyl ester (CAPE) ameliorates cisplatin-induced hepatotoxicity in rabbit
Kart, A., Çiğremiş, Y., Karaman, M., & Özen, H. (2009) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2009.02.066 · Cited by 122
Al‐Majed, A. A., Sayed‐Ahmed, M. M., Al‐Yahya, A. A., Aleisa, A. M., Al-Rejaie, S. S., & Al‐Shabanah, O. A. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2005.12.005 · Cited by 115
Protective Effects of Erdosteine on Doxorubicin-induced Hepatotoxicity in Rats
Yağmurca, M., Baş, O., Mollaoğlu, H., et al. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.01.007 · Cited by 114
Erdosteine prevents doxorubicin-induced cardiotoxicity in rats
Yağmurca, M., Fadıllıoğlu, E., Erdoğan, H., Uçar, M., Söğüt, S., & Irmak, M. K. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00185-3 · Cited by 111
The development of platinum compounds and their possible combination
Pasetto, L. M., D'Andrea, M. R., Brandes, A. A., Rossi, E. G., & Monfardini, S. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.02.003 · Cited by 109
Zhou, B., Li-jun, W., Li, L., Tashiro, S., Onodera, S., Uchiumi, F., & Ikejima, T. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fpj06005x · Cited by 105
Rao, P. R., & Viswanath, R. K. (2007) · PubMed Central · Cited by 93
Martinis, B. S. D., & Bianchi, M. D. L. P. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0860 · Cited by 81
The effect of L-carnitine in the prevention of ionizing radiation-induced cataracts: a rat model
Koçer, İ., Tayşi, S., Ertekin, M. V., Karslıoğlu, İ., Gepdíremen, A., Sezen, O., & Şerifoğlu, K. (2006) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-005-0097-1 · Cited by 80
Chlopčíková, Š., Psotová, J., Miketová, P., & Šimánek, V. (2004) · Phytotherapy Research · doi:10.1002/ptr.1415 · Cited by 78
Prevention of singlet oxygen-induced DNA damage by lipoate
Devasagayam, T. P. A., Subramanian, M., Pradhan, D. S., & Sies, H. (1993) · Chemico-Biological Interactions · doi:10.1016/0009-2797(93)90113-d · Cited by 77
Yáñez, J. A., Teng, X. W., Roupe, K., Fariss, M. W., & Davies, N. M. (2003) · PubMed · Cited by 67
Wieckowski, M. R., Brdiczka, D. G., & Wojtczak, L. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02127-x · Cited by 65
Jayavelu, T., Jayaraman, G., Sivarajan, K., & Panneerselvam, C. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.08.028 · Cited by 56
Bist, R., & Bhatt, D. K. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.09.008 · Cited by 49
Zhou, B., Wu, L.-J., Tashiro, S.-I., Onodera, S., Uchiumi, F., & Ikejima, T. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1900 · Cited by 41
Nicolson, G. L., & Conklin, K. A. (2008) · Current Cancer Therapy Reviews · doi:10.2174/157339408783565484 · Cited by 26
Lõster, H., & Böhm, U. (2001) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007255021484 · Cited by 23
Carnitine and Lipoic Acid Alleviates Protein Oxidation in Heart Mitochondria During Aging Process
Sethumadhavan, S., & Panneerselvam, C. (2006) · Biogerontology · doi:10.1007/s10522-006-6497-8 · Cited by 21
Schneider, L. A., Dissemond, J., Brenneisen, P., Hainzl, A., Briviba, K., Wlaschek, M., & Scharffetter‐Kochanek, K. (2005) · Archives of Dermatological Research · doi:10.1007/s00403-005-0611-7 · Cited by 19
Proceedings of the Second International Symposium on Clinical Enzymology
Tietz, N. W., Weinstock, A., & Rodgerson, D. O. (1976) · Cited by 14
., A. R. M. A. G., ., S. E. A., & ., S. A. A. O. (2001) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2001.604.607 · Cited by 11
Cited by
The side effects of platinum-based chemotherapy drugs: a review for chemists
Oun, R., Moussa, Y. E., & Wheate, N. J. (2018) · Dalton Transactions · doi:10.1039/c8dt00838h · Cited by 1,737
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
Surai, P. (2015) · Antioxidants · doi:10.3390/antiox4010204 · Cited by 738
Advances in Toxicological Research of the Anticancer Drug Cisplatin
Qi, L., Luo, Q., Zhang, Y., Jia, F., Zhao, Y., & Wang, F. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00204 · Cited by 440
Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy
Tchounwou, P. B., Dasari, S., Noubissi, F. K., Ray, P., & Kumar, S. (2021) · Journal of Experimental Pharmacology · doi:10.2147/jep.s267383 · Cited by 384
Polk, A., Vaage-Nilsen, M., Vistisen, K., & Nielsen, D. L. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.03.005 · Cited by 329
Metadata
- Authors
- El-Awady, E.-S. E., Moustafa, Y. M., Abo-Elmatty, D. M., & Radwan, A.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 650
- Issue
- 1
- Pages
- 335-341
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2086591885
- Cited by
- 260
- References
- 59
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.